Defense World
19 Apr 2026, 08:26 UTC · 22w ago
Verdict
Headline takes no side. We score NTLA +0.60 across five claims — strongly bullish.
+0.60strongly bullish
More positive than 70% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Intellia Therapeutics reported quarterly revenue of $23.02 million, beating the consensus estimate of $12.17 million and representing 78.4% year-over-year growth.
So whatA near-100% top-line surprise and strong year-over-year growth significantly improves the fundamental outlook and cash run rate for a clinical-stage biotech.
More positive than 99% of claims this week
Intellia Therapeutics reported quarterly EPS of ($0.83), beating the consensus estimate of ($0.99).
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 76% of claims this week
HC Wainwright lifted its price objective on Intellia Therapeutics from $25.00 to $30.00 and maintained a 'buy' rating.
So whatA $5 increase in a price target from a bullish firm signals improved conviction, providing a notable upside signal relative to the current trading price.
More positive than 69% of claims this week
Contrarius Group Holdings Ltd grew its holdings in Intellia Therapeutics by 279.4% in the third quarter, acquiring an additional 4,337,428 shares.
More positive than 62% of claims this week
Wells Fargo and RBC each lifted their price objectives on Intellia Therapeutics to $15.00, from $12.00 and $9.00 respectively, while maintaining neutral ratings.
So whatUpward revisions in price targets from neutral-rated analysts reflect fundamental improvements, but the conservative targets limit the bullish impact.
More positive than 55% of claims this week
Which stocks this story touches
More positive than 70% of ticker scores this week
Positive momentum driven by increased institutional ownership, multiple price target raises, and an earnings beat on both top and bottom lines.
More negative than 73% of ticker scores this week
Slightly negative as Massachusetts Financial Services Co. MA lowered its holdings in the company.
More positive than 40% of ticker scores this week
Slightly positive due to the report of a new purchase by Venturi Wealth Management LLC.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Invezz
3h ago
Seeking Alpha
4h ago
−18.8%
Price is moving against the score
$12.14 vs $14.95 close before publication (Apr 17) · not market-adjusted
NTLA chart →
